Anti-oxidant Containing Nanostructured Lipid Carriers of Ritonavir: Development, Optimization, and In Vitro and In Vivo Evaluations

INIS

• acquired immunodeficiency syndrome 10%
• biological availability 20%
• buffers 10%
• calorimetry 10%
• carriers 100%
• comparative evaluations 10%
• curves 10%
• doses 10%
• drugs 70%
• efficiency 20%
• emulsions 10%
• evaluation 100%
• fourier transform spectrometers 10%
• humans 20%
• in vitro 100%
• in vivo 100%
• lipids 100%
• liquids 20%
• management 10%
• nanostructures 100%
• optimization 100%
• oxidants 100%
• particle size 10%
• ph value 10%
• phosphates 10%
• range 20%
• screening 10%
• side effects 20%
• size 10%
• solids 10%
• suspensions 10%
• therapy 20%
• tocopherols 10%
• viruses 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Acquired Immune Deficiency Syndrome 10%
• Alpha Tocopherol 10%
• Antioxidant 100%
• Antivirus Agent 10%
• Bioavailability 20%
• Buffer 10%
• Differential Scanning Calorimetry 10%
• Drug 30%
• Drug Release 20%
• Excipient 20%
• Fourier Transform Infrared Spectroscopy 10%
• HIV 20%
• Infection 10%
• Lipid 100%
• Lopinavir 10%
• Nitrogen Mustard 10%
• Pharmacokinetic Parameter 10%
• Pharmacokinetics 30%
• Phosphate 10%
• Proteinase Inhibitor 20%
• Ritonavir 100%
• Side Effect 20%
• Zeta Potential 20%